Blood, 2022-11, Vol.140 (Supplement 1), p.6142-6144
- Pigneux, Arnaud
- Dumas, Pierre-Yves
- Bernard, Marc
- Vey, Norbert
- Bidet, Audrey
- Mineur, Ariane
- Hunault, Mathilde
- Carre, Martin
- Ojeda, Mario
- Banos, Anne
- Peterlin, Pierre
- Guieze, Romain
- Desbrosses, Yohan
- Roth Guepin, Gabrielle
- Simand, Celestine
- Leguay, Thibaut
- Gyan, Emmanuel
- Jourdan, Eric
- Vial, Jean-Philippe
- Marchand, Tony
- Hicheri, Yosr
- Bene, Marie C
- Hamel, Jean Francois
- Recher, Christian
2022
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Pigneux, Arnaud
- Dumas, Pierre-Yves
- Bernard, Marc
- Vey, Norbert
- Bidet, Audrey
- Mineur, Ariane
- Hunault, Mathilde
- Carre, Martin
- Ojeda, Mario
- Banos, Anne
- Peterlin, Pierre
- Guieze, Romain
- Desbrosses, Yohan
- Roth Guepin, Gabrielle
- Simand, Celestine
- Leguay, Thibaut
- Gyan, Emmanuel
- Jourdan, Eric
- Vial, Jean-Philippe
- Marchand, Tony
- Hicheri, Yosr
- Bene, Marie C
- Hamel, Jean Francois
- Recher, Christian
- Titel
- Epag 2015 : A Phase II Randomized Placebo-Controlled Study to Assess the Impact on Outcome of Eltrombopag Administered to Elderly Patients with Acute Myeloid Leukemia Receiving Induction Chemotherapy. a French Innovative Leukemia Organization (FILO) Study
- Ist Teil von
- Blood, 2022-11, Vol.140 (Supplement 1), p.6142-6144
- Ort / Verlag
- Elsevier Inc
- Erscheinungsjahr
- 2022
- Quelle
- Alma/SFX Local Collection
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0006-4971eISSN: 1528-0020DOI: 10.1182/blood-2022-167000Titel-ID: cdi_crossref_primary_10_1182_blood_2022_167000
- Format
- –